TNFSF13
Tumor necrosis factor ligand superfamily member 13
Also known as: APRIL, CD256, TNF13_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75888
- Gene
- TNFSF13
- Ensembl
- ENSG00000161955
- Chromosome
- 17
- Canonical length
- 250 aa
- Protein class
- Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the tumor necrosis factor (TNF) ligand family. This protein is a ligand for TNFRSF17/BCMA, a member of the TNF receptor family. This protein and its receptor are both found to be important for B cell development. In vitro experiments suggested that this protein may be able to induce apoptosis through its interaction with other TNF receptor family proteins such as TNFRSF6/FAS and TNFRSF14/HVEM. Alternative splicing results in multiple transcript variants. Some transcripts that skip the last exon of the upstream gene (TNFSF12) and continue into the second exon of this gene have been identified; such read-through transcripts are contained in GeneID 407977, TNFSF12-TNFSF13. [provided by RefSeq, Oct 2010]
Canonical amino-acid sequenceUniProt
250 residues, UniProt reviewed canonical sequence.
>O75888|TNFSF13
1 MPASSPFLLA PKGPPGNMGG PVREPALSVA LWLSWGAALG AVACAMALLT QQTELQSLRR
61 EVSRLQGTGG PSQNGEGYPW QSLPEQSSDA LEAWENGERS RKRRAVLTQK QKKQHSVLHL
121 VPINATSKDD SDVTEVMWQP ALRRGRGLQA QGYGVRIQDA GVYLLYSQVL FQDVTFTMGQ
181 VVSREGQGRQ ETLFRCIRSM PSHPDRAYNS CYSAGVFHLH QGDILSVIIP RARAKLNLSP
241 HGTFLGFVKLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFSF13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 170 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 170 nTPM
- salivary gland: 139 nTPM
- lung: 89 nTPM
- duodenum: 70 nTPM
- kidney: 62 nTPM
- gallbladder: 51 nTPM
Single-cell type
- astrocytes: 28 nCPM
- microglia: 12 nCPM
- bergmann glia: 7.9 nCPM
- choroid plexus epithelial cells: 7 nCPM
- ependymal cells: 5.8 nCPM
- monocytes: 3.5 nCPM
Immune cell
- classical monocyte: 384 nTPM
- intermediate monocyte: 364 nTPM
- myeloid DC: 249 nTPM
- non-classical monocyte: 236 nTPM
- total PBMC: 222 nTPM
- eosinophil: 139 nTPM
Brain region
- choroid plexus: 98 nTPM
- thalamus: 47 nTPM
- medulla oblongata: 47 nTPM
- basal ganglia: 43 nTPM
- midbrain: 43 nTPM
- pons: 39 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.82
- gnomAD missense Z
- 0.53
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- immune response
- lymphocyte homeostasis
- positive regulation of B cell proliferation
- positive regulation of cell population proliferation
- positive regulation of isotype switching to IgA isotypes
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFSF13 as an antibody target. Whether an autoantibody or antibody against TNFSF13 could matter depends on whether native TNFSF13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFSF13 is annotated as secreted, so native TNFSF13 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label TNFSF13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...